Lepius Life Sciences Private Limited
About Lepius Life Sciences Private Limited
Data last updated:
Lepius Life Sciences Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC092527. Its GSTIN is 24AADCL0884F1ZO (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Krunal Chhaganbhai Patel and Nileshkumar Mahipatray Ahir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.74 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹35.51 Lakh (net margin -36.7%) and EBITDA of -₹35.1 Lakh (EBITDA margin -36.3%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 18% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lepius Life Sciences Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.03 Rishabh Homes, Nr. Devbhumi Society Nr. Adarsh Tenament Opp Lalita Society, Ahmedabad, Gujarat, India – 382443
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lepius Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lepius Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lepius Life Sciences Private Limited, buy the company report.
Financials of Lepius Life Sciences Private Limited
FY 2025 filings availableLepius Life Sciences Private Limited reported revenue of ₹96.74 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 22% fall in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹35.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹35.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -36.3% | ||||
| Net Profit Margin | -36.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lepius Life Sciences Private Limited, buy the company report.
Board of directors of Lepius Life Sciences Private Limited
Lepius Life Sciences has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krunal Chhaganbhai Patel | Director | 17 Jun 2016 | 10 Years 4 Months | Current |
| Nileshkumar Mahipatray Ahir | Director | 17 Jun 2016 | 10 Years 4 Months | Current |
| Bhagyeshkumar Babulal Patel Also directs: Atulit Jewels LLP | Director | 17 Jun 2016 | 10 Years 4 Months | Current |
| Chandreshbhai Chhaganbhai Bhut Also directs: Labh Minstone Private Limited | Director | 17 Jun 2016 | 10 Years 4 Months | Current |
| Jayesh Mahipatbhai Ahir | Director | 05 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Lepius Life Sciences Private Limited is audited by SURESH R SHAH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURESH R SHAH & ASSOCIATES | FY 2023 | 110691W |
Shareholding
The shareholding of Lepius Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lepius Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lepius Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Lepius Life Sciences Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 21 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aster Life Science | |||
| Sterlife Biotec | |||
| Accretion Pharmaceuticals | |||
| Sterlife Pharma Private Limited | |||
| Erva Healthcare Private Limited |
To see the full MSME payment records of Lepius Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lepius Life Sciences Private Limited has a workforce of 23 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Lepius Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCL0884F1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lepius Life Sciences Private Limited, buy the company report.
Recent activity
Lepius Life Sciences Private Limited has 6 board changes on record since 2016: 5 appointments and 1 cessation. The latest: Jayesh Mahipatbhai Ahir was appointed as Director on 05 Jul 2025.
Frequently asked questions
Lepius Life Sciences is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 June 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC092527.
Lepius Life Sciences has 5 current directors:
- Krunal Chhaganbhai Patel - Director
- Nileshkumar Mahipatray Ahir - Director
- Bhagyeshkumar Babulal Patel - Director
- Chandreshbhai Chhaganbhai Bhut - Director
- Jayesh Mahipatbhai Ahir - Director
The latest financial statements of Lepius Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Lepius Life Sciences is 24AADCL0884F1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Lepius Life Sciences is U74999GJ2016PTC092527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lepius Life Sciences was incorporated on 17 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jayesh Mahipatbhai Ahir was appointed as Director on 05 Jul 2025. Hiteshkumar Vrajlal Gajera ceased to be Director on 22 Feb 2021. Bhagyeshkumar Babulal Patel was appointed as Director on 17 Jun 2016. Lepius Life Sciences has 6 board changes on record in total.
Lepius Life Sciences has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 21 overdue payments to 7 micro and small suppliers. The latest return was filed on 09 Jun 2019.
The registered office of Lepius Life Sciences is at Shop No.03 Rishabh Homes, Nr. Devbhumi Society Nr. Adarsh Tenament Opp Lalita Society, Ahmedabad, Gujarat, India – 382443.
Lepius Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Lepius Life Sciences is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.